Tonic inhibition of somatostatin on C and Adelta afferent fibers in rat dorsal skin in vivo.
The purpose of this study was to investigate the effect of somatostatin (SST) in peripheral nerve terminals using local application of the SST receptor (SSTR) antagonist cyclo-somatostatin (c-SOM) injected into the receptive fields of cutaneous afferent fibers innervating the dorsal hairy skin in anesthetized rats. Single unit activity was recorded in teased filaments from the dorsal cutaneous nerve branch. Recordings were obtained from 206 primary afferent fibers. They were classified as C (n=70), Adelta (n=84) or Abeta (n=52) fibers based upon their conduction velocity. For C and Adelta fibers, mean discharge rate increased and mechanical threshold decreased significantly to 10 microL of 12.8 and 128 microM injected subcutaneously, but not to 0.128 and 1.28 microM c-SOM injection. For Abeta fibers, no dose of c-SOM changed their discharge rate or their mechanical sensitivity. In control experiments, injection of normal saline (NS) had no effect on any of the units tested. Octreotide (20 microM, 10 microL), an SSTR agonist, successfully reversed the increase in discharge rates and the decrease in mechanical thresholds in C and Adelta fibers when it was pre-administrated into the receptive field before c-SOM injection. These results provide evidence that somatostatin tonically inhibits the peripheral nerve terminals of small-diameter cutaneous afferent fibers.
Wang
Jun
J
Department of Physiology and Pathophysiology, Xi'an Jiaotong University School of Medicine, Xi'an, Shaanxi 710061, PR China.
Guo
Yuan
Y
Cao
Dong-Yuan
DY
Luo
Rong
R
Ma
Shao-Jie
SJ
Wang
Hui-Sheng
HS
Pickar
Joel G
JG
Zhao
Yan
Y
D000200:Action Potentials / Q000187:drug effects / Q000502:physiology; D000818:Animals; D004305:Dose-Response Relationship, Drug; D007279:Injections, Subcutaneous; D009413:Nerve Fibers, Myelinated / Q000187:drug effects* / Q000502:physiology; D036421:Nerve Fibers, Unmyelinated / Q000187:drug effects* / Q000502:physiology; D009431:Neural Conduction / Q000187:drug effects / Q000502:physiology; D009475:Neurons, Afferent / Q000187:drug effects / Q000502:physiology; D015282:Octreotide / Q000494:pharmacology; D010456:Peptides, Cyclic / Q000494:pharmacology; D051381:Rats; D012684:Sensory Thresholds / Q000187:drug effects; D012867:Skin / Q000187:drug effects* / Q000294:innervation; D013004:Somatostatin / Q000502:physiology*; D013127:Spinal Nerves / Q000187:drug effects
D010456:Peptides, Cyclic; C067675:cyclosomatostatin; D013004:Somatostatin; D015282:Octreotide